Citadel Advisors’s Genprex GNPX Stock Holding History

Citadel Advisors’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Hold	0	–	-$364	–	14668
2023 Q1	–	Hold	0	–	–	–	14512
2022 Q4	–	Hold	0	–	–	–	13779
2022 Q1	–	Sell	-1	Closed	-$39K	–	13967
2021 Q4	$39K	Hold	1	–	–	﹤0.01%	13380
2021 Q3	$110K	Hold	1	–	–	﹤0.01%	12758
2021 Q2	$148K	Hold	1	–	–	﹤0.01%	12518
2021 Q1	$240K	Hold	1	–	–	﹤0.01%	11329
2020 Q4	$188K	Buy	+1	New	+$155K	﹤0.01%	9785
2020 Q3	–	Sell	-1	Closed	-$158K	–	9470
2020 Q2	$84K	Buy	+1	New	+$122K	﹤0.01%	9085

Other funds holding GNPX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Citadel Advisors's GNPX Position: Q1 2024 in Review

Citadel Advisors sold out of Genprex (GNPX) in Q1 2024, closing a stake of 4 shares — an estimated $44K sold.

Citadel Advisors first reported a position in GNPX in Q2 2019 and held it in 8 quarters. The position peaked at $81K in Q1 2022. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

Citadel Advisors reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
Citadel Advisors sold 4 Genprex shares in Q1 2024, an estimated $44K.
Citadel Advisors first reported a position in Genprex in Q2 2019 and held it in 8 quarters.
Citadel Advisors's Genprex position peaked at $81K in Q1 2022.
8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.